Provenance Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Provenance Wealth Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.27K	Buy	98 +7	+8%	+$460	﹤0.01%	371
2026 Q1	$6.48K	Buy	+91	New	+$7.18K	﹤0.01%	331
2025 Q4	–	Sell	-91	Closed	-$6.83K	–	433
2025 Q3	$6.83K	Hold	91	–	–	﹤0.01%	344
2025 Q2	$6.74K	Hold	91	–	–	﹤0.01%	330
2025 Q1	$7.34K	Hold	91	–	–	﹤0.01%	332
2024 Q4	$7.11K	Hold	91	–	–	﹤0.01%	343
2024 Q3	$8.54K	Buy	+91	New	+$7.64K	﹤0.01%	346
2024 Q2	–	Sell	-91	Closed	-$8.27K	–	527
2024 Q1	$8.27K	Buy	+91	New	+$7.57K	﹤0.01%	328

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Provenance Wealth Advisors's GEHC Position: Q2 2026 in Review

Provenance Wealth Advisors increased its GE HealthCare (GEHC) stake by 7.7% in Q2 2026, buying an estimated $460 and bringing the position to 98 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Provenance Wealth Advisors first reported a position in GEHC in Q1 2024 and has held it in 8 quarters since. The position peaked at $8.54K in Q3 2024. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Provenance Wealth Advisors held 98 shares of GE HealthCare worth $6.27K as of Q2 2026.
Provenance Wealth Advisors bought 7 GE HealthCare shares in Q2 2026, an estimated $460.
GE HealthCare made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #371 holding.
Provenance Wealth Advisors first reported a position in GE HealthCare in Q1 2024 and has held it in 8 quarters since.
Provenance Wealth Advisors's GE HealthCare position peaked at $8.54K in Q3 2024.
1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.